BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8557015)

  • 1. Hypothermic cardiopulmonary bypass influences the concentration-response relationship and the biodisposition of rocuronium.
    Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():91-4. PubMed ID: 8557015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium.
    Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):700-5. PubMed ID: 8664462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans.
    Beaufort AM; Wierda JM; Belopavlovic M; Nederveen PJ; Kleef UW; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():95-106. PubMed ID: 8557016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
    Khuenl-Brady KS; Sparr H; PĆ¼hringer F; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.
    Wierda JM; Proost JH; Schiere S; Hommes FD
    Eur J Anaesthesiol Suppl; 1994; 9():66-74. PubMed ID: 7925212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
    Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance doses of vecuronium and pancuronium during hypothermic cardiopulmonary bypass].
    Ohnishi Y; Uchida O; Nakajima T; Kitaguchi K; Takaki O; Ohsumi H; Kuro M
    Masui; 1993 Jul; 42(7):995-1001. PubMed ID: 8102414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery.
    Asokumar B; Cheng D; Chung F; Peniston C; Sandler A; Varin F
    Can J Anaesth; 1998 Jun; 45(6):515-20. PubMed ID: 9669003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: assessment of the prospective predictive accuracy and the quality of anesthesia.
    Barvais L; Heitz D; Schmartz D; Maes V; Coussaert E; Cantraine F; d'Hollander A
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):402-8. PubMed ID: 10972605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
    Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of neuromuscular block in morbidly obese patients following an infusion of rocuronium.
    Spoelders K; van Duffel L; Vandermeersch E; Adriaenssens G; Van de Velde M
    Acta Anaesthesiol Belg; 2001; 52(3):293-5. PubMed ID: 11732386
    [No Abstract]   [Full Text] [Related]  

  • 18. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.